25-hydroxyvitamin D3 Supplementation Research Articles

Effects of Supplementation of 25-Hydroxyvitamin D3 as a Vitamin D3 Substitute on Performance, Bone Traits, and Egg Quality of Laying Hens from 1 Day to 72 Weeks of Age

This experiment was conducted to explore the effect of long-term supplementation of 25-hydroxyvitamin D3 (25-OHD) as a vitamin D3 (VD3) substitute on performance, bone traits, and egg quality of laying hens from 1 day to 72 weeks of age. In total, 900 one-day-old Lohman pullets were randomly allotted into three dietary groups (three treatments × 15 replicates × 20 birds per replicate): VD3 2800 IU/kg; 25-OHD 69 μg/kg; 25-OHD 125 μg/kg. At the end of the 20th w, five replicates from each group were selected to feed on the same vitamin D diets, as used during the rearing stage (1–20 w) until 72 w. The result showed that the 25-OHD 125 μg/kg treatment had the lowest average daily feed intake (ADFI) at 1–8 or 1–19 w, body weight at 8 w, body weight gain between 1 and 8 w and shank length at 4 w (p < 0.05). The 25-OHD 125 μg/kg treatment had a lower shank length at 7 w, compared with the 25-OHD 69 μg/kg treatment. The shank length of the birds in each treatment reached the maximum (about 103 mm) at about 18 w of age. For the bone traits, the 25-OHD 125 μg/kg treatment had the lowest femur bone diameter at 20 w (p < 0.001) and femur bone plumpness at 20 w (p = 0.002). The 25-OHD 125 μg/kg treatment had a lower tibia strength at 10 w (p = 0.023) and keel length at 10 w (p = 0.046), compared with the 25-OHD 69 μg/kg treatment. However, both 25-OHD 69 and 125 μg/kg treatments had a greater femur strength at 72 w (p = 0.006), compared with the VD3 2800 IU/kg treatment. No difference in laying performance was observed among all treatments. The overall (21–72 w) ADFI in the 25-OHD 125 μg/kg treatment was significantly lower than that in the 25-OHD 69 μg/kg treatment (p = 0.030). At 60 w, the 25-OHD 125 μg/kg treatment had a lower eggshell thickness (p = 0.012) and proportion of eggshell (p = 0.022), compared with the 25-OHD 69 μg/kg treatment. No significant differences in egg quality parameters were observed at 50 and 70 w among treatments. In general, supplementary 2800 IU/kg doses of VD3 at the early stage were sufficient to maintain the bone quality and growth and development of pullets. Feeding birds at a higher 25-OHD level (125 μg/kg) resulted in the reduced ADFI and growth at the rearing period, but the long-term supplementation of 25-OHD as a VD3 substitute improved the bone quality in the late laying period.

Dietary Supplementation of 25-Hydroxyvitamin D3 Improves Growth Performance, Antioxidant Capacity and Immune Function in Weaned Piglets.

This study was conducted to evaluate the effects of 25-hydroxyvitamin D3 (25(OH)VD3) and Vitamin D3 (VD3) supplemented in the diet of weaned piglets on their growth performance, bone quality, intestinal integrity, immune function and antioxidant capacity. A total of 192 weaned piglets were allocated into four groups and they were fed a control diet containing 2000 IU VD3 (negative control, NC), NC + 100 ppm colistin sulfate (positive control, PC), NC + 2000 IU VD3 (VD3) and NC + 2000 IU 25(OH)VD3 (25(OH)VD3). The results showed that 25(OH)VD3 improved the growth performance, bone quality and antioxidase activity of piglets compared with the other groups. Meanwhile, 25(OH)VD3 up-regulated ileal mRNA expressions of tight junction proteins and host defense peptides. The VD3 group had an increased intestinal sIgA content and mRNA expression of pBD-1 compared with the NC group. Both groups of VD3 and 25(OH)VD3 altered the microbial β-diversity compared with the NC group, and 25(OH)VD3 increased ileal concentrations of acetate and butyrate. In conclusion, our findings indicated that a regular dosage of 2000 IU VD3 in the weaned piglets’ diet did not achieve optimal antioxidant capacity and immune function. 25(OH)VD3 had better growth performance than VD3 at the same inclusion level, which is associated with the improved intestinal integrity and antioxidant capacity.

Fresh and cryopreserved semen, minerals, hormones and health characteristics in response to reciprocal combinations of vitamin D3 and 25-hydroxyvitamin D3 in the mature and prepubertal Holstein bulls' diet

The objective of this study was to evaluate the effect of supplementation of 25-hydroxyvitamin D3 (25(OH)VD3) instead of vitamin D3 on the quality and seminal plasma antioxidant indicators of fresh and cryopreserved semen, serum minerals, vitamin D3 status, hormone levels, blood biochemistry, antioxidant and immune function in different age of bulls. Thirty-two Holstein bulls (16 bulls aged 24–36 months and weighted 727 ± 99.0 kg; 16 bulls aged 12 months and weighted 332 ± 24.9 kg) randomly assigned to 1 of 4 treatments in a 2 × 2 factorial arrangement with 2 sources of vitamin D3 (vitamin D3 or 25(OH)VD3) fed at 300 IU/kg dry matter intake and two different age of bull (maturity or prepuberty) through a 60 day period. Bulls were tied in individual pens without access to sunlight. Bulls fed 25(OH)VD3 had greater semen concentration (P = 0.03), sperms motility (P = 0.02), viability (P < 0.001), membrane integrity (P < 0.001) and seminal plasma antioxidant capacity (P < 0.05) at fresh stage compared with bulls fed vitamin D3. In addition, 25(OH)VD3 increased sperms motility (P = 0.02) and membrane integrity (P = 0.04) in cryopreserved semen. Feeding 25(OH)VD3 increased serum total calcium (P = 0.03), total phosphorus (P < 0.001), 25(OH)VD3 (P < 0.001), 1,25-dihydroxyvitamin D3 (P < 0.001) compared with dietary vitamin D3. Feeding 25(OH)VD3 improved concentrations of serum estradiol (P = 0.02), testosterone (P = 0.003) and growth hormone (P < 0.001) and decreased serum cortisol (P = 0.01). Lower blood urea nitrogen (P = 0.005), creatinine (P = 0.02), aspartate aminotransferase (P = 0.005) and higher serum glucose (P = 0.03) were observed in the 25(OH)VD3. Dietary 25(OH)VD3 increased serum glutathione (P = 0.001) and immunoglobulin M (P = 0.03) and decreased malondialdehyde (P = 0.04) compared to those fed vitamin D3. The total antioxidant capacity was affected by interaction of age and vitamin D source (P < 0.001). In conclusion, replacing vitamin D3 with 25(OH)VD3 improved semen quality and benefited health of the mature and prepubertal Holstein bulls.

Role of long-term supplementation of 25-hydroxyvitamin D3 on egg production and egg quality of laying hen

A study was conducted to evaluate the effect of dietary 25-hydroxyvitamin D3 (25OHD) on pullet and egg-laying hen growth performance, egg production, and egg quality. Three hundred and ninety 1-day-old Hy-Line W36 pullets were randomly allocated to 3 treatments with 10 replicated cages and 13 birds per cage. Dietary treatments were vitamin D3 at 2,760 IU/kg (D); vitamin D3 at 5,520 IU/kg (DD), and vitamin D3 at 2,760 IU/kg plus 25OHD at 2,760 IU (69 μg)/kg (25D). Body weight and feed intake were recorded at the end of each stage: starter 1 (0–3 wk), starter 2 (4–6 wk), grower (7–12 wk), developer (13–15 wk), prelay (15–17 wk), peaking (18–38 wk), layer 2 (39–48 wk), layer 3 (49–60 wk), layer 4 (61–75 wk), and layer 5 (76–95 wk). Egg production was recorded daily. Egg quality was evaluated every 8 wk starting from 25 wk. There was no difference in growth performance during the rearing period (0–17 wk). In the laying period (18–95 wk), DD showed lower feed intake at layer 2, but higher intake at layer 3 along with lower hen day production (HDP) from 22 to 48 wk compared to the other treatments. During the same period, the DD group laid smaller eggs with higher specific gravity and shell thickness compared with the other treatments or D alone at 40 wk, which may be partly due to the lower body weight. In contrast, 25D had better feed conversion ratio (feed intake per dozen of eggs) at layer 2, and higher overall (22–60 wk) HDP compared with DD. For the egg quality analysis, at 25 and 33 wk, both DD and 25D had higher Haugh unit compared with D. However, 25OHD has no effects on eggshell quality during the entire production period and no beneficial effects on egg production during the later laying period (after 60 wk). In summary, long-term and early supplementation of 25OHD has positive effects on egg production and egg quality, and the beneficial effects were mainly observed during the early laying stage.

Role of long-term supplementation of 25-hydroxyvitamin D3 on laying hen bone 3-dimensional structural development

Egg-laying hens have a unique bone development pattern due to the medullary bone formation and high bone turnover rate. The role of long-term supplementation of an intermediate form of vitamin D3, 25-hydroxyvitamin D3 (25OHD), on skeletal development of pullets and laying hens is not well established. Exploring its effects on layer bone development will help develop a strategy for preventing laying hen osteoporosis. The purpose of this study was to investigate the role of long-term supplementation of 25OHD in layer diets on bone 3-dimensional structural development. A total of 390 1-day-old Hy-Line W36 pullets were randomly allocated to 3 treatments with 10 replicate cages and 13 birds/cage. Dietary treatments were 1) vitamin D3 at 2,760 IU/kg, 2) vitamin D3 at 5,520 IU/kg, and 3) vitamin D3 at 2,760 IU/kg plus 25OHD at 2,760 IU (69 μg)/kg. The level of 25OHD in the serum was tested throughout the whole experimental period (0–95 wk). Bone growth rate (BGR) was measured at 10 wk using a calcein injection technique. Femurs were scanned using Micro-CT for 3D structural analysis, and the whole-body composition analysis was performed using a dual-energy x-ray absorptiometry method at 17, 60, and 95 wk. Dietary supplementation of 25OHD significantly increased 25OHD level in the serum from 0 to 95 wk. During the rearing period (0–17 wk), 25OHD increased BGR, cortical tissue volume, and bone marrow area at 17 wk, simultaneously. 25OHD created more pores in cortical bone, which resulted in a lower cortical bone mineral density (BMD) but without alerting bone mineral content (BMC). This effect allowed more space for mineral deposition in bones during the later egg-laying period. At 60 wk, the 25OHD group had significantly greater BMD, which led to the highest total BMC, cortical volume, and trabecular bone connectivity. At 95 wk, the birds fed 25OHD had significantly higher cortical bone volume and lower porosity. The 25OHD group also had higher total BMD and medullary bone volume but a lower BMC and volume of trabecular bone than vitamin D3 or double dosage vitamin D3 treatment. This indicated that the bone resorption rate was lower in cortical bone than that in trabecular bone in the late laying period. In conclusion, supplementation with dietary 25OHD could stimulate bone growth and increase bone volume in pullets to provide more space for mineral deposition during the laying period with positive effects on laying hen bone quality.

Oral Supplementation of the Vitamin D Metabolite 25(OH)D3 Against Influenza Virus Infection in Mice.

Vitamin D is a fat-soluble vitamin that is metabolized by the liver into 25-hydroxyvitamin D [25(OH)D] and then by the kidney into 1,25-dihydroxyvitamin D [1,25(OH)2D], which activates the vitamin D receptor expressed in various cells, including immune cells, for an overall immunostimulatory effect. Here, to investigate whether oral supplementation of 25-hydroxyvitamin D3 [25(OH)D3], a major form of vitamin D metabolite 25(OH)D, has a prophylactic effect on influenza A virus infection, mice were fed a diet containing a high dose of 25(OH)D3 and were challenged with the influenza virus. In the lungs of 25(OH)D3-fed mice, the viral titers were significantly lower than in the lungs of standardly fed mice. Additionally, the proinflammatory cytokines IL-5 and IFN-γ were significantly downregulated after viral infection in 25(OH)D3-fed mice, while anti-inflammatory cytokines were not significantly upregulated. These results indicate that 25(OH)D3 suppresses the production of inflammatory cytokines and reduces virus replication and clinical manifestations of influenza virus infection in a mouse model.

Influence of the combination of 25-hydroxyvitamin D3 and a diet negative in cation-anion difference on peripartal calcium homeostasis of dairy cows

Around parturition, many dairy cows experience varying degrees of hypocalcemia, which increases the incidence of several diseases in early lactation. In the current study, an established concept of feeding a diet negative in cation-anion difference (DCAD) was combined with oral supplementation of 25-hydroxyvitamin D3 (25-OHD3) from d 270 of gestation until parturition. Fifty-six dairy cows were divided into 2 feeding groups (low DCAD and control). Fourteen animals of each group received a daily dosage of 3mg of 25-OHD3. From the beginning of the treatment to d 10 after parturition, plasma samples for analysis of 25-OHD3, 1,25-dihydroxyvitamin D3, parathyroid hormone (PTH), Ca2+, phosphate, the bone resorption marker CrossLaps, and osteocalcin were collected every other day, at calving, and at 6, 12, and 24h after calving. Urine samples for determination of macrominerals and measures of acid-base status were collected on d 6 of treatment and on d 6 after calving. The induction of a compensated metabolic acidosis by the animals on the DCAD diet could be demonstrated by decreased urinary pH. A linear correlation between treatment duration and the plasma concentration of 25-OHD3 indicated effective absorption of 25-OHD3 in supplemented animals. The mean plasma concentrations of Ca2+ from d −4 prepartum to d 4 postpartum were significantly higher in animals treated with the combination of the low DCAD diet and 25-OHD3 supplementation (1.24±0.02mmol/mL) compared with the 3 other groups (low DCAD: 1.17±0.02 mmol/mL; control diet plus 25-OHD3: 1.16±0.02 mmol/mL; control diet: 1.18±0.02 mmol/mL). We postulate that the increased tissue responsiveness to parathyroid hormone induced by the low DCAD is crucial for the observed positive effects of the 25-OHD3 treatment.